Skip to main content

CITIGROUP INC

Position in LKFT — Lakefront Biotherapeutics NV

CIK 831001 NEW YORK, NY

Position in LKFT

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$10,612
-$4,328 QoQ
Shares Held
354
-28.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Derivatives in LKFT

reported options exposure · as of Sep 30, 2025
CallValue
$1,039,200
CallShares
30,000
PutValue
$1,039,200
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,091,289,244 across 384 Biotechnology names. LKFT ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,612 354
2026-03-31 $14,940 498
2025-12-31 $13,210 404
2025-09-30 $479,867 13,853
2025-09-30 $1,039,200 30,000
2025-09-30 $1,039,200 30,000
2025-06-30 $21,720 776
2025-03-31 $746,013 29,698
2024-12-31 $821,012 29,855
2024-09-30 $865,081 30,048
2024-06-30 $748,503 30,206
2024-03-31 $966,000 30,000
2024-03-31 $1,762,531 54,737
2024-03-31 $966,000 30,000
2023-12-31 $5,197,061 127,849
2023-12-31 $1,219,500 30,000
2023-12-31 $1,219,500 30,000
2023-09-30 $3,133,201 90,686
2023-06-30 $50,215 1,235
2023-03-31 $51,777 1,340
2022-12-31 $76,910 1,733
2022-09-30 $57,265 1,343
2022-06-30 $81,970 1,469
2022-03-31 $369,018 5,950
2021-12-31 $403,992 7,328
2021-09-30 $426,509 8,107
2021-06-30 $626,415 9,093
2021-03-31 $32,916 427
2020-12-31 $9,936,699 100,391
2020-09-30 $14,271,179 100,565
2020-06-30 $20,640,281 104,619
2020-03-31 $20,531,632 104,796